← Back to Clinical Trials
Recruiting NCT07182019

NCT07182019 Connecting Today to Combat Social Isolation and Loneliness

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07182019
Status Recruiting
Phase
Sponsor University of Alberta
Condition Dementia in Nursing Home
Study Type INTERVENTIONAL
Enrollment 320 participants
Start Date 2026-06-09
Primary Completion 2026-09-30

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Connecting Today

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 320 participants in total. It began in 2026-06-09 with a primary completion date of 2026-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The investigators developed Connecting Today, a feasible and highly acceptable remote visiting program that can support care home residents living with moderate to severe dementia to have video calls with their family members, friends, or care partners. The investigators will recruit 80 residents from 4 care homes, and their family members, friends, or care partners. All participants will be offered 60 minutes of Connecting Today per week for 6 weeks (in either the intervention group, or in the wait-list control group). An onsite care provider will be trained to tailor the video calls, and facilitate positive verbal and non-verbal engagement during the calls. The investigators will evaluate how Connecting Today affects outcomes for residents (quality of life, loneliness, and responsive behaviours) and their remote visitors (quality of life, loneliness, and social support). The investigators will assess how outcomes differ for men, women, and people with different perceptions and experiences of Connecting Today.

Eligibility Criteria

Inclusion Criteria: Residents: * are at least 65 years old * are diagnosed with any type of dementia * have a Cognitive Performance Score (CPS) indicating moderate to severe impairment (CPS 3-6). * to participate, residents must also have people that self identify as a family member or friend of the person with dementia. Remote visitors: * are people that self-identify as a family member or friend of the person with dementia * are people with whom the person with dementia desires contact * are 18 or older * understand and speak English. Exclusion Criteria: * All remote visitors are required to understand and speak English as this is necessary for the facilitator to support the call and for data to be collected.

Contact & Investigator

Central Contact

Hannah O'Rourke, PhD

✉ hannah.orourke@ualberta.ca

📞 780-492-7961

Principal Investigator

Hannah O'Rourke, PhD

PRINCIPAL INVESTIGATOR

University of Alberta

Frequently Asked Questions

Who can join the NCT07182019 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Dementia in Nursing Home. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07182019 currently recruiting?

Yes, NCT07182019 is actively recruiting participants. Contact the research team at hannah.orourke@ualberta.ca for enrollment information.

Where is the NCT07182019 trial being conducted?

This trial is being conducted at Edmonton, Canada.

Who is sponsoring the NCT07182019 clinical trial?

NCT07182019 is sponsored by University of Alberta. The principal investigator is Hannah O'Rourke, PhD at University of Alberta. The trial plans to enroll 320 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology